Kent-Athlone Pharma Group divests Athlone Laboratories to Gaelic Laboratories

Kent-Athlone Pharma Group has completed the sale of Athlone Laboratories Limited to Gaelic Laboratories. Athlone Laboratories, based in Ballymurray, Co. Roscommon, manufactures essential oral antibiotics, including amoxicillin, flucloxacillin and penicillin products.

The divestment supports Kent-Athlone’s strategy to focus on developing and commercialising Value-Added Medicines as an asset-light European specialty pharmaceutical company. Gaelic Laboratories will invest in the site, expand production and employment, and strengthen Europe-based antibiotic supply.

Kent-Athlone will continue marketing products manufactured by Athlone Laboratories, primarily in the UK and Ireland, under a long-term manufacturing and supply partnership. Athlone Pharmaceuticals remains part of Kent-Athlone Pharma Group and is unaffected by the transaction.

Share the Post:

Related Posts

Athlone Pharmaceuticals has officially joined Medicines for Ireland (MFI).

Read More

Athlone Pharmaceuticals Joins the AMR Industry Alliance to Support Global Action Against Antimicrobial Resistance

Read More